Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board of Directors
Health Catalyst to Participate in Upcoming Investor Conferences
Health Catalyst Inc (HCAT) Q3 2025 Earnings Call Highlights: Strong Technology Growth Amid ... [Yahoo! Finance]
Health Catalyst (NASDAQ:HCAT) had its price target lowered by analysts at Citigroup Inc. from $3.50 to $3.25. They now have a "neutral" rating on the stock.
Health Catalyst (NASDAQ:HCAT) had its price target lowered by analysts at Stifel Nicolaus from $4.50 to $3.75. They now have a "hold" rating on the stock.